Replies to post #8666 on Mast Therapeutics Inc (fka MSTX)

[dreamonjon]

Timing of events might be considered too contrived, too eager, lacking finesse, I agree, especially in lieu of similar patterns in the last year, R/S the most stunning example. I am certainly frustrated by yesterday and was disappointed that the company is so thirsty to express its efficiency. It seems amateurish, like someone who just won the lottery who just can't wait to make a big splashy/obnoxious impression on his friends. Yet, despite the lack of tempered demeanor, I still think, though, that there is more than 1 person involved in making these moves, and that there is a consensus amongst the movers and they most likely know something that I am willing to stick around and find out about. Too many entities involved all seemingly too eager, that is my opinion.

[ExPatriate57]

Chris,

From Brians Forbes profile:

He received a B.S. in biology from Boston College, an M.S. in biochemistry from the University of California, Santa Barbara and an M.B.A. from The Johnson School of Business at Cornell University with an emphasis on private equity and entrepreneurship.

http://people.forbes.com/profile/brian-m-culley/1758

Unfortunately, because I was using this as a short term trade (based on the FDA 514 meeting and pending 530 NDA filing acceptance), I hadn't done the proper in-depth DD on managements background.

Now that I have... this doesn't surprise me in the least.

Icahn, Kostas, Culley... they're running this like a PE venture that's funded through a public offering with the vast amount of shares in "weak hands"...

... guess what? They're right.

I expect this management team to do nothing organically (look at the three named individuals backgrounds) they'll use every success as a way to raise capital to fund new acquistions/expansion.

I just wish I'd have known this before this past week. My bad.